Ophthalmic Diagnostic Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Ophthalmic Diagnostic Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Ophthalmic Diagnostic Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Ophthalmic Diagnostic Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Ophthalmic Diagnostic Equipment used in the examination of the eye which allows study or treatment of different pathologies of the eye.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Ophthalmic Diagnostic Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Ophthalmic Diagnostic Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Ophthalmic Diagnostic Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
About GlobalData
Introduction
Ophthalmic Diagnostic Equipment Overview
Products under Development
Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development
Table Figure 1: Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development
Table Ophthalmic Diagnostic Equipment - Pipeline Products by Stage of Development
Ophthalmic Diagnostic Equipment - Pipeline Products by Segment
Table Tear Film Imager (TFI) - COVID-19 - Study to Compare the Efficacy of Tear Film Imager Versus Current Standard of Care for Detection of COVID-19 within the Surface of the Eye
Cambridge University Hospitals NHS Foundation Trust Company Overview
Cambridge University Hospitals NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
Table Cambridge University Hospitals NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
Table Neocam Digital Imaging Device - Product Status
Table Neocam Digital Imaging Device - Product Description
Table Cambridge University Hospitals NHS Foundation Trust - Ongoing Clinical Trials Overview
Table Neocam Digital Imaging Device - Can the Diagnostic Accuracy of Newborn Eye Screening for Congenital Cataract be Improved With Digital Dual Light Source Imaging? The Digital Imaging vs Ophthalmoscopy (DIvO)Study
Canon USA Inc Company Overview
Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Duke University - Ongoing Clinical Trials Overview
Table Microscope Integrated OCT System - Optimize Pediatric OCT (Optical Coherence Tomography) Imaging: a Pilot Study
Table Whole Eye Optical Coherence Tomography Scanner - Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 2 and School Age Follow on Study
Duke-NUS Graduate Medical School Company Overview
Duke-NUS Graduate Medical School Pipeline Products & Ongoing Clinical Trials Overview
Table Duke-NUS Graduate Medical School Pipeline Products & Ongoing Clinical Trials Overview
Table Pupillometer Device - Glaucoma Dx - Product Status
Table EQ103 - An Exploratory Study in Healthy Adult Volunteers to Evaluate the Best Corrected Visual Acuity (BCVA) Performance of a Handheld Device Compared with a Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction
Table EQ103 - An Exploratory Study in Healthy Pediatric Volunteers to Evaluate the Performance of a Handheld Device Compared with Standard Eye Care Diagnostic Device in Measuring Ophthalmic Refraction
Eyoto Group Ltd Company Overview
Eyoto Group Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table Notal Home OCT System - Evaluation of Repeated, In-Clinic, Self-Imaging by DME Patients Using the Notal Vision
Table Notal Home OCT System - Home OCT Fluid Visualization Agreement Study at Multiple Retinal Clinics with Placement of One Home OCT Device in the Home of Each NV-AMD Subject in the US for 5 Weeks
Table Notal Home OCT System - Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD
Table Notal Home OCT System - Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
Nova Southeastern University Company Overview
Nova Southeastern University Pipeline Products & Ongoing Clinical Trials Overview
Table Nova Southeastern University Pipeline Products & Ongoing Clinical Trials Overview
Table Visual Field Evaluation Equipment - Product Status
Table Visual Field Evaluation Equipment - Product Description
Dec 08, 2023: Zilia Receives 510(K) Clearance For Zilia Ocular FC (ZIL-10002)
Nov 29, 2023: Zilia Receives FDA Clearance for Its Zilia Ocular FC Retinal Camera
Nov 21, 2023: Revenio Group Announces Financial Reporting and AGM in 2024
Nov 15, 2023: Topcon Medical Systems Receives 510(K) Clearance For Maestro2
Nov 10, 2023: Huvitz Receives 510(K) Clearance For Applanation Tonometer HT-5000
Nov 08, 2023: RetinalGeniX Contracts With Avania CRO to Provide Guidance for Interactions With FDA on Development of Two Drug Therapies and the RetinalCam Image Visualization Device
Nov 05, 2023: Heidelberg Engineering Receives Additional 510(K) Clearance for Spectralis HRA+OCT
Nov 03, 2023: Optomed Announces Interim Report, January - September 2023
Oct 27, 2023: Aeye Health and Topcon Screen Announce Partnership to Enhance Point-Of-Care Diabetic Retinopathy Screening with Best-In-Class AI Technology
Oct 26, 2023: Revenio Group Corporation: Interim report January 1 - September 30, 2023
Oct 24, 2023: Implandata Announces Appointment of New Members Dr. Adrienne Graves and Jan Willem de Cler to Join Board of Directors
Oct 13, 2023: Heidelberg Engineering Announces FDA Clearance for All-in-One ANTERION Platform
Oct 02, 2023: Marco Rizzardo appointed as Vice President, R&D and a member of the Leadership Team of Revenio Group
Sep 21, 2023: Neolight Receives 510(k) Clearance for Phoenix ICON GO Imaging System
Sep 18, 2023: Retinalgenix Technologies Focuses on Prevention of Blindness and Early Detection of Multiple Systemic Diseases
Sep 08, 2023: Ocean Insight Names Richard Curran as President
Sep 07, 2023: New Multicenter Study Reveals Neurological Pupil Index (NPi) As Predictor of Outcome and Mortality in Brain Injury Patients
Sep 07, 2023: Canon Makes Director Changes
Sep 05, 2023: Optos Receives an Additional 510(k) Clearance for P200TE
Sep 05, 2023: Bruker's New NeuraLeap Delivers Unprecedented Imaging Speed Across Optical Planes
Aug 15, 2023: Alcon Reports Second Quarter 2023 Results
Aug 10, 2023: Revenio Group Announces Half-Year Financial Report 1 January-30 June 2023
Aug 03, 2023: Juho Himberg has been appointed CEO of Optomed
Jul 31, 2023: RetinalGeniX's patient home monitoring system receives patent
Jul 12, 2023: VISIA Imaging Receives Additional 510(k) Clearance for MYAH - Corneal Topography System
Jul 11, 2023: IRIS and AEYE Health Announce Partnership to Provide AI Screening to Market
Jun 22, 2023: New FDA Clearance Makes Eyenuk the First Company with Multiple Cameras for Autonomous AI Detection of Diabetic Retinopathy
May 18, 2023: Gland Pharma announces statement of audited consolidated financial results for the quarter and year ended March 31, 2023
May 10, 2023: Optomed Announces Decisions of the Annual General Meeting and Board of Directors
May 09, 2023: Optomed and Thirona Retina establish an AI partnership
Apr 27, 2023: Revenio Group Announces Interim report January 1-March 31, 2023
Apr 26, 2023: Carl Zeiss Meditec receives additional 510(k) clearance for Cirrus HD-OCT
Apr 26, 2023: Canon Announces Consolidated Results For The First Quarter Ended March 31, 2023
Apr 25, 2023: OPKO Health to report Q1 2023 financial results on May 3, 2023
Apr 24, 2023: RetinAI and Boehringer partner to develop geographic atrophy treatments
Apr 06, 2023: Welch Allyn receives 510(k) clearance for iExaminer System With Panoptic Plus
Apr 03, 2023: Optomed Notice Of The Annual General Meeting
Mar 29, 2023: Canon Publishes Annual Report for the Year Ended December 31, 2022
Mar 23, 2023: Revenio Group Corp. Decisions by the Annual General Meeting
Mar 21, 2023: OcuSciences announces publication showing potential to detect retinal diseases with high sensitivity
Mar 13, 2023: Phelcom Technologies receives 510(k) clearance for Eyer Retinal Camera NM-STD
Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
Mar 02, 2023: Optomed Announces Annual Report 2022
Mar 01, 2023: Revenio Group Notice to the Annual General Meeting
Feb 24, 2023: ArgusClarity OCT System by MicroPort Argus registered for marketing in Singapore
Feb 16, 2023: Eyenuk Welcomes Paul Praino as Chief Commercial Officer
Feb 16, 2023: OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
Feb 15, 2023: Xoran Technologies Expands Board of Managers
Feb 15, 2023: Simple method to isolate outer nuclear layer in fluorescent retinal images on cellprofiler
Feb 10, 2023: Carl Zeiss Meditec achieves further revenue growth in First quarter 2022/23
Feb 08, 2023: Study shows novel Flavoprotein fluorescence measure is correlated with age-related macular degeneration (AMD) stage
Feb 02, 2023: Tracey Technologies announces new features with version 7.0 upgrade
Jan 30, 2023: Canon Announces Consolidated Results For The Fourth Quarter And The Fiscal Year Ended December 31, 2022
Jan 30, 2023: Topcon Announces Consolidated Financial Results for the Third Quarter of FY2022 Ending March 2023
Jan 24, 2023: AEYE Health announces best-in-class results, proving AI software is capable of predicting the future development of diabetic retinopathy in patients before diagnosable symptoms manifest
Jan 23, 2023: Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2022 Financial Results on February 22
Jan 23, 2023: Gland Pharma's Q3FY23 Revenue stood at 9,383 Mn with Gross margin of 54%
Jan 19, 2023: OcuSciences announces publication of study showing novel flavoprotein fluorescence measure is increased in inherited retinal dystrophies
Jan 10, 2023: New clinical study shows NeurOptics' Neurological Pupil Index, an important value for assessing brain injury, is unaffected by clinical intoxication